Ligand depletion negatively controls the mitogenic activity of epidermal growth factor

Experimental Cell Research

Volumn 304, Issue 2, 2005, Pages 630-641

  Van De Poll, Monique L M ^a   Van Rotterdam, Walter ^a   Gadellaa, Mireille M ^a   Jacobs Oomen, Saskia ^a   Van Zoelen, Everardus J J ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Epidermal growth factor mutant; ErbB1 overexpression; Ligand degradation; Mitogenic stimulation; Receptor internalisation

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NOTCH RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BREAST TUMOR; CELL CYCLE S PHASE; CHIMERA; CONTROLLED STUDY; DEPLETION; ENZYME ACTIVITY; EXTRACELLULAR SPACE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR CELL CULTURE;

EID: 14644420231     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.12.011     Document Type: Article

References (40)

1. M.H. Kirschbaum, and Y. Yarden The ErbB/HER family of receptor tyrosine kinases: a potential target for chemoprevention of epithelial neoplasms J. Cell. Biochem., Suppl. 34 2000 52 60
2. J. Baselga Why the epidermal growth factor receptor? The rationale for cancer therapy Oncologist 7 2002 2 8
3. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat. Rev., Mol. Cell Biol. 2 2001 127 137
4. A.W. Burgess, H.S. Cho, C. Eigenbrot, K.M. Ferguson, T.P. Garrett, D.J. Leahy, M.A. Lemmon, M.X. Sliwkowski, C.W. Ward, and S. Yokoyama An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors Mol. Cell 12 2003 541 552
5. E.J. Van Zoelen The use of biological assays for detection of polypeptide growth factors Prog. Growth Factor Res. 2 1990 131 152
6. D.W. Barnes Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture J. Cell Biol. 93 1982 1 4
7. I. Alroy, and Y. Yarden The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions FEBS Lett. 410 1997 83 86
8. R. Ebner, and R. Derynck Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes Cell Regul. 2 1991 599 612
9. H. Waterman, and Y. Yarden Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases FEBS Lett. 490 2001 142 152
10. A.V. Vieira, C. Lamaze, and S.L. Schmid Control of EGF receptor signaling by clathrin-mediated endocytosis Science 274 1996 2086 2089
11. H.S. Wiley Trafficking of the ErbB receptors and its influence on signaling Exp. Cell Res. 284 2003 78 88
12. Y. Wang, S. Pennock, X. Chen, and Z. Wang Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival Mol. Cell. Biol. 22 2002 7279 7290
13. C.C. Reddy, A. Wells, and D.A. Lauffenburger Comparative mitogenic potencies of EGF and TGF alpha and their dependence on receptor-limitation versus ligand-limitation Med. Biol. Eng. Comput. 36 1998 499 507
14. V.G. Riddle, A.B. Pardee, and P.W. Rossow Growth control of normal and transformed cells J. Supramol. Struct. 11 1979 529 538
15. S.M. Jones, and A. Kazlauskas Growth-factor-dependent mitogenesis requires two distinct phases of signalling Nature Cell Biol. 3 2001 165 172
16. S. Pennock, and Z. Wang Stimulation of cell proliferation by endosomal epidermal growth factor receptor as revealed through two distinct phases of signaling Mol. Cell. Biol. 23 2003 5803 5815
17. D.J. Knauer, H.S. Wiley, and D.D. Cunningham Relationship between epidermal growth factor receptor occupancy and mitogenic response. Quantitative analysis using a steady state model system J. Biol. Chem. 259 1984 5623 5631
18. F. Walker, E. Nice, L. Fabri, F.J. Moy, J.F. Liu, R. Wu, H.A. Scheraga, and A.W. Burgess Resistance to receptor-mediated degradation of a murine epidermal growth factor analogue (EGF-Val-47) potentiates its mitogenic activity Biochemistry 29 1990 10635 10640
19. C.C. Reddy, S.K. Niyogi, A. Wells, H.S. Wiley, and D.A. Lauffenburger Engineering epidermal growth factor for enhanced mitogenic potency Nat. Biotechnol. 14 1996 1696 1699
20. S.M. Puddicombe, L. Wood, S.G. Chamberlin, and D.E. Davies The interaction of an epidermal growth factor/transforming growth factor alpha tail chimera with the human epidermal growth factor receptor reveals unexpected complexities J. Biol. Chem. 271 1996 30392 30397
21. M.L. Van de Poll, M.J. Van Vugt, A.E. Lenferink, and E.J. Van Zoelen Insertion of Argos sequences into the B-loop of epidermal growth factor results in a low-affinity ligand with strong agonistic activity Biochemistry 36 1997 7425 7431
22. M.L. Van de Poll, M.J. Van Vugt, A.E. Lenferink, and E.J. Van Zoelen Identification of the minimal requirements for binding to the human epidermal growth factor (EGF) receptor using chimeras of human EGF and an EGF repeat of Drosophila Notch J. Biol. Chem. 273 1998 16075 16081
23. A. Honegger, T.J. Dull, F. Bellot, E. Van Obberghen, D. Szapary, A. Schmidt, A. Ullrich, and J. Schlessinger Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites EMBO J. 7 1988 3045 3052
24. C.I. Sartor, M.L. Dziubinski, C.L. Yu, R. Jove, and S.P. Ethier Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells Cancer Res. 57 1997 978 987
25. B. Van der Burg, G.R. Rutteman, M.A. Blankenstein, S.W. De Laat, and E.J. Van Zoelen Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen J. Cell. Physiol. 134 1988 101 108
26. M.L. Van de Poll, A.E. Lenferink, M.J. Van Vugt, J.J. Jacobs, J.W. Janssen, M. Joldersma, and E.J. Van Zoelen A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptor J. Biol. Chem. 270 1995 22337 22343
27. A.E. Lenferink, R.H. Kramer, M.J. Van Vugt, M. Konigswieser, P.P. Di Fiore, E.J. Van Zoelen, and M.L. Van de Poll Superagonistic behaviour of epidermal growth factor/transforming growth factor-alpha chimaeras: correlation with receptor routing after ligand-induced internalization Biochem. J. 327 1997 859 865
28. E. Tzahar, J.D. Moyer, H. Waterman, E.G. Barbacci, J. Bao, G. Levkowitz, M. Shelly, S. Strano, R. Pinkas-Kramarski, J.H. Pierce, G.C. Andrews, and Y. Yarden Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network EMBO J. 17 1998 5948 5963
29. M.J. Van de Vijver, R. Kumar, and J. Mendelsohn Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly J. Biol. Chem. 266 1991 7503 7508
30. M. Korc, and J.E. Finman Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor-alpha J. Biol. Chem. 264 1989 14990 14999
31. C.C. Reddy, A. Wells, and D.A. Lauffenburger Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect Biotechnol. Prog. 10 1994 377 384
32. D.J. Knauer, H.S. Wiley, and D.D. Cunningham Relationship between epidermal growth factor receptor occupancy and mitogenic response. Quantitative analysis using a steady state model system J. Biol. Chem. 259 1984 5623 5631
33. A.E. Lenferink, E.J. Van Zoelen, M.J. Van Vugt, S. Grothe, W. Van Rotterdam, M.L. Van de Poll, and M.D. O'Connor-McCourt Superagonistic activation of ErbB-1 by EGF-related growth factors with enhanced association and dissociation rate constants J. Biol. Chem. 275 2000 26748 26753
34. A.E. Lenferink, R. Pinkas-Kramarski, M.L. Van de Poll, M.J. Van Vugt, L.N. Klapper, E. Tzahar, H. Waterman, M. Sela, E.J. Van Zoelen, and Y. Yarden Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers EMBO J. 17 2000 3385 3397
35. L.F. Gulli, K.C. Palmer, Y.Q. Chen, and K.B. Reddy Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity Cell Growth Differ. 7 1996 173 178
36. R.K. Matsunami, M.L. Yette, A. Stevens, and S.K. Niyogi Mutational analysis of leucine 47 in human epidermal growth factor J. Cell. Biochem. 46 1991 242 249
37. S.G. Chamberlin, L. Brennan, S.M. Puddicombe, D.E. Davies, and D.L. Turner Solution structure of the mEGF/TGFalpha44-50 chimeric growth factor Eur. J. Biochem. 268 2001 6247 6255
38. J. Baulida, M.H. Kraus, A. Alimandi, P.P. Di Fiore, and G. Carpenter All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired J. Biol. Chem. 271 1996 5251 5257
39. A.E. DeWitt, J.Y. Dong, H.S. Wiley, and D.A. Lauffenburger Quantitative analysis of the EGF receptor autocrine system reveals cryptic regulation of cell response by ligand capture J. Cell Sci. 114 2001 2301 2313
40. A. DeWitt, T. Iida, H.Y. Lam, V. Hill, H.S. Wiley, and D.A. Lauffenburger Affinity regulates spatial range of EGF receptor autocrine ligand binding Dev. Biol. 250 2002 305 316